InvestorsHub Logo
Followers 62
Posts 7601
Boards Moderated 1
Alias Born 01/02/2003

Re: dukesking post# 375903

Friday, 04/29/2022 11:38:21 AM

Friday, April 29, 2022 11:38:21 AM

Post# of 428673
Duke...I agree about an AG form of Vascepa

The main scientific advantage Vascepa has over gV is its patented capsule that prevents oxidation of EPA...Amarin has not yet produced evidence of this effect...even though there have been compelling reasons for them to have done the studies... Although there have been rumors that research is being done on this issue,,.we have not seen definitive results from these studies.

Until we do hear more about this research, the main distinguishing features between Vascepa and gV remain the slightly lower price of gV and the lack of any clinical trials of gV.

Until we have the authority to market a once a day statin-MD2119 product, we should commence marketing of an AG of Vascepa.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News